Clinical significance of cytologic diagnosis of atypical squamous cells, cannot exclude high grade, in perimenopausal and postmenopausal women.

We used cytohistologic correlation to determine the clinical significance of atypical squamous cells, cannot exclude high grade (ASC-H) in perimenopausal and postmenopausal women. A computer search identified 250 Papanicolaou smears from women older than 45 years with a diagnosis of ASC- H. Cases were considered perimenopausal (45 to < 55 years; 150 cases) and postmenopausal ((3)55 years; 100 cases). No follow-up data were available for 33 cases, which were excluded. The remaining 217 cases (perimenopausal, 127; postmenopausal, 90) had surgical or cytologic follow-up. Results of follow-up colposcopic biopsy were available for 176 (81.1%) and cytology for 41 (18.9%) women. Follow-up results were as follows: perimenopausal women, negative, 50 (39.4%); mild dysplasia (low-grade squamous intraepithelial lesion [LSIL]), 46 (36.2%); high-grade dysplasia (high-grade SIL [HSIL]); 28 (22.0%); and ASC of undetermined significance (ASC-US), 3 (2.4%); postmenopausal women, negative, 52 (58%); LSIL, 31 (34%); HSIL, 5 (6%); and ASC-US, 2 (2%). The diagnosis of ASC-H in postmenopausal women usually is associated with LSIL or a negative diagnosis on follow-up, suggesting a less aggressive surveillance and treatment regimen is needed for postmenopausal women with ASC-H.

[1]  R. Saad,et al.  Cytomorphologic analysis and histological correlation of high‐grade squamous intraepithelial lesions in postmenopausal women , 2006, Diagnostic cytopathology.

[2]  B. Ronnett,et al.  Atypical squamous cells, cannot exclude high‐grade squamous intraepithelial lesion , 2005, Cancer.

[3]  T. Bonfiglio,et al.  Should women with atypical squamous cells, cannot exclude high‐grade squamous intraepithelial lesion, receive reflex human papillomavirus‐DNA testing? , 2005, Cancer.

[4]  Lisa D. Duncan,et al.  Atypical squamous cells, cannot exclude a high‐grade squamous intraepithelial lesion: The practice experience of a hospital‐based reference laboratory with this new Bethesda system diagnostic category , 2005, Diagnostic cytopathology.

[5]  L. Rowe,et al.  Prevalence and typing of HPV DNA by hybrid capture II in women with ASCUS, ASC‐H, LSIL, and AGC on ThinPrep® Pap tests , 2004, Diagnostic cytopathology.

[6]  Patricia Gingrich Management and follow-up of abnormal Papanicolaou tests. , 2004, Journal of the American Medical Women's Association.

[7]  Diane Solomon,et al.  The Bethesda System for Reporting Cervical Cytology , 2004 .

[8]  I. Eltoum,et al.  Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion. A follow-up study of conventional and liquid-based preparations in a high-risk population. , 2003, American journal of clinical pathology.

[9]  S. Selvaggi Reporting of atypical squamous cells, cannot exclude a high‐grade squamous intraepithelial lesion (ASC‐H) on cervical samples: Is it significant? , 2003, Diagnostic cytopathology.

[10]  Syed Z. Ali,et al.  Atypical squamous cells of undetermined significance—rule out high‐grade squamous intraepithelial lesion: Cytopathologic characteristics and clinical correlates , 2003, Diagnostic cytopathology.

[11]  K. Behbakht,et al.  Histologic findings from the cervix among older women with abnormal cervical cytology. , 2003, Gynecologic oncology.

[12]  Thomas C Wright,et al.  2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. , 2002, Journal of lower genital tract disease.

[13]  Mark Sherman,et al.  The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.

[14]  Thomas C Wright,et al.  Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities , 2002 .

[15]  M. Sherman,et al.  Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. , 2001, American journal of clinical pathology.

[16]  T. Kline,et al.  ASCUS, Mature Metaplastic Type , 2001, Acta Cytologica.

[17]  M. Hutchinson,et al.  Atypical squamous metaplastic cells , 2001, Cancer.

[18]  D. Salomão,et al.  Small cells in cervical‐vaginal smears of patients treated with tamoxifen , 2001, Cancer.

[19]  D. Rimm,et al.  Diagnosis of “ASCUS” in women over age 50 is less likely to be associated with dysplasia , 2001, Diagnostic cytopathology.

[20]  T. Kline,et al.  ASCUS, mature metaplastic type. Cytologic diagnosis and follow-up. , 2001, Acta cytologica.

[21]  K. Kerlikowske,et al.  The Positive Predictive Value of Cervical Smears in Previously Screened Postmenopausal Women: The Heart and Estrogen/progestin Replacement Study (HERS) , 2000, Annals of Internal Medicine.

[22]  A. Hanselaar,et al.  Proliferation in "atypical" atrophic pap smears. , 2000, Gynecologic oncology.

[23]  M. Duggan,et al.  Cytologic and Histologic Diagnosis and Significance of Controversial Squamous Lesions of the Uterine Cervix , 2000, Modern Pathology.

[24]  Koss Lg Correspondence re: Sherman ME, Tabbara SO, Scott DR, Kurman RJ, Glass AG, Manos MM, et al. "Ascus, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol 1999;12:335-42. , 2000 .

[25]  Deqin Sun,et al.  Atypical immature metaplastic-like proliferations of the cervix: diagnostic reproducibility and viral (HPV) correlates. , 1999, Human pathology.

[26]  S. Raab,et al.  Long-term outcome and relative risk in women with atypical squamous cells of undetermined significance. , 1999, American journal of clinical pathology.

[27]  F. Abdul-Karim,et al.  Atypical Squamous Cells of Undetermined Significance in Women Over 55 , 1999, Acta Cytologica.

[28]  M. Sherman,et al.  "ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[29]  S. Wilczynski,et al.  Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patients , 1998, Diagnostic cytopathology.

[30]  A. Abati,et al.  Squamous atypia in the atrophic cervical vaginal smear , 1998, Cancer.

[31]  J. Kurinczuk,et al.  The "Inconclusive‐Possible high grade epithelial abnormality" category in papanicolaou smear reporting , 1998, Cancer.

[32]  C. Crum,et al.  Qualifying the cytologic diagnosis of "atypical squamous cells of undetermined significance" affects the predictive value of a squamous intraepithelial lesion on subsequent biopsy. , 1998, Archives of pathology & laboratory medicine.

[33]  A. Ferenczy,et al.  Human Papillomavirus Infection in Postmenopausal Women With and Without Hormone Therapy , 1997, Obstetrics and gynecology.

[34]  D. Wilbur,et al.  Atypical squamous cells of undetermined significance. Stratification of the risk of association with, or progression to, squamous intraepithelial lesions based on morphologic subcategorization. , 1997 .

[35]  W. Frable,et al.  Atypical squamous cells of undetermined significance: Correlative histologic and follow‐up studies from an academic medical center , 1997, Diagnostic cytopathology.

[36]  W. Welch,et al.  Postmenopausal squamous atypia: a spectrum including "pseudo-koilocytosis". , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[37]  D. Davey,et al.  Atypical squamous cells of undetermined significance: Interlaboratory comparison and quality assurance monitors , 1994, Diagnostic cytopathology.

[38]  T. Kline,et al.  Postmenopausal squamous‐cell atypias: A diagnostic challenge , 1994, Diagnostic cytopathology.

[39]  G. Nuovo,et al.  Correlation of Cervical Cytology and Human Papillomavirus DNA Detection in Postmenopausal Women , 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[40]  M. Boon,et al.  Exploiting the "toothpick effect" of the Cytobrush by plastic embedding of cervical samples. , 1991, Acta cytologica.

[41]  B. Ramsahoye,et al.  Cytological changes preceding cervical cancer , 2022 .